Key result
Elevated IL-6 linked to ~54% higher ASCVD risk independent of Life's Essential 8 score.
Why the study?
Despite the known link between cardiovascular disease and inflammation, the American Heart Association's Life's Essential 8 metrics do not incorporate inflammatory markers.
Does a higher Life's Essential 8 (LE8) score and lower inflammatory burden reduce the risk of ASCVD and all-cause mortality in a community-based population?
Cohort (n=1,869)
No
Does a higher Life's Essential 8 (LE8) score and lower inflammatory burden reduce the risk of ASCVD and all-cause mortality in a community-based population?
Answers are grounded in this paper and cite their sources.
Higher Life's Essential 8 scores are associated with lower ASCVD and all-cause mortality, but elevated IL-6 remains an independent risk factor for ASCVD even after accounting for LE8.
Background: Life's Essential 8 (LE8) are the key health behaviors and factors for improving and maintaining cardiovascular health, as defined by the American Heart Association. However, despite the association of cardiovascular diseases with inflammation, LE8 does not include inflammatory markers as a component. We analyzed the longitudinal association of LE8 components and inflammatory measures with health outcomes among a community-based population. Methods: Baseline LE8 metrics and inflammatory markers (interleukin-6 [IL-6] and high sensitivity C-reactive protein [hsCRP]) were measured among 1,869 participants (age 59±7.5 years, 41.9% Black) in the longitudinal Heart SCORE study. Cox-proportional hazard ratios were used to assess the association of incident atherosclerotic cardiovascular disease (ASCVD) and all-cause mortality across quartiles of LE8 score, and to assess inflammatory markers as an independent risk factor. Results: Compared to the lowest quartile, all higher quartiles of LE8 Score were significantly associated with lower risk of all-cause mortality and ASCVD over a median of 12 years of follow-up. After adjusting for all other LE8 metrics as well as by age, sex, race and socioeconomic risk, ideal level of blood glucose was the single most significant factor associated with lower risk of ASCVD (HR 0.26 [0.12-0.58], p=0.001). For all-cause mortality, no smoking emerged as the main protective LE8 component (HR 0.29 [0.16-0.53], p<0.001). When added to LE8, interleukin-6 (IL-6) was independently associated with ASCVD (HR 1.54 [1.05-2.25], p=0.03),while lower IL-6 was associated with lower all-cause mortality (HR 0.52 [0.30-0.90] p=0.02). HsCRP was not associated with either outcome. Conclusions: Higher LE8 Score and metrics are associated with lower risk of all-cause and ASCVD mortality as well as non-fatal events in this longitudinal cohort of White and Black adults. Additionally, elevated IL-6 levels were associated with higher risk of ASCVD and all-cause mortality even when accounting for total LE8 score. Future studies should investigate the role of modifying inflammatory burden in addition to LE8 components in prevention of adverse health outcomes.
No takes yet. Share an insight, caveat, or question.
Bambs et al. (2025) conducted a cohort in Cardiovascular disease risk (n=1,869). Interleukin-6 (IL-6) and Life's Essential 8 (LE8) Score vs. Lowest quartile of LE8 score / lower IL-6 levels was evaluated on Composite of ASCVD mortality and nonfatal ASCVD events (HR 1.54, 95% CI 1.05-2.25, p=0.028). Elevated interleukin-6 levels were independently associated with a higher risk of atherosclerotic cardiovascular disease even when accounting for total Life's Essential 8 score.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: